Roussel Uclaf S.A. was a French pharmaceutical company and one of several predecessor companies of today's Sanofi. It was the second largest French pharmaceutical...

Julien Gaston Roussel, who was President and General Manager of the Roussel Uclaf Laboratoires Pharmaceutiques, and his wife, Francine Grinda, daughter...

Paris. He later obtained an MBA at HEC Paris. In April 1986, he joined Roussel Uclaf (formerly France's second largest pharmaceutical company, until bought...

mifepristone for personal use in 1989, a decision supported by Roussel Uclaf. In 1994, Roussel Uclaf gave the U.S. drug rights to the Population Council in exchange...

Merrell Dow of Kansas City, Missouri forming U.S. subsidiary Hoechst Marion Roussel (HMR). 1997 — Hoechst underwent a realignment wherein its various businesses...

French automobile manufactured from 1908 to 1914 Roussel Uclaf, a French pharmaceutical company Big Roussel, the channel between Herm to the west, and Brecqhou...

corporation Hoechst Marion Roussel, which itself was formed from the 1995 merger of Hoechst AG with Cassella, Roussel Uclaf, and Marion Merrell Dow. Hoechst...

nonsteroidal antiandrogen (NSAA) which was initially developed in the 1980s by Roussel Uclaf, the French pharmaceutical company from which it received its name....

& Company). Hoechst's new pharmaceutical company became Hoechst Marion Roussel and kept its North American headquarters in Kansas City. Hoechst in turn...

RU-28362 is a synthetic androstane glucocorticoid that was developed by Roussel Uclaf. It is a selective agonist of the glucocorticoid receptor (corticoid...